- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Change in Director's Interest Notice - Toby Hall | - | ASX | ||
| 22.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Change of Director's Interest Notice - Ian Kadish | - | ASX | ||
| 22.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | - | ASX | ||
| 19.12.25 | Goldman Sachs startet Beobachtung von Integral Diagnostics mit "Sell"-Rating | 2 | Investing.com Deutsch | ||
| 19.12.25 | Goldman Sachs initiates Integral Diagnostics stock with Sell rating | 1 | Investing.com | ||
| INTEGRAL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 16.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Change of Director's Interest Notice - Ian Kadish | - | ASX | ||
| 16.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | - | ASX | ||
| 16.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 16.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 16.12.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 09.11.25 | INTEGRAL DIAGNOSTICS LIMITED: Appointment of Managing Director and Chief Executive Officer | - | ASX | ||
| 31.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Results of Annual General Meeting | - | ASX | ||
| 21.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Release of Ordinary Shares from Escrow | - | ASX | ||
| 13.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 13.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 13.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Notification regarding unquoted securities - IDX | 1 | ASX | ||
| 06.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Application for quotation of securities - IDX | 1 | ASX | ||
| 06.10.25 | INTEGRAL DIAGNOSTICS LIMITED: Change in Director's Interest Notice - Toby Hall | 1 | ASX | ||
| 29.09.25 | INTEGRAL DIAGNOSTICS LIMITED: 2025 Notice of Annual General Meeting | - | ASX | ||
| 25.09.25 | INTEGRAL DIAGNOSTICS LIMITED: FY25 Sustainability Report | 1 | ASX |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics reports Strong Preliminary Q4 2025 Topline Growth | ||
| FRESENIUS MEDICAL CARE | 39,560 | +1,41 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| MIMEDX | 6,310 | -2,02 % | MiMedx Group, Inc: MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel | MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to... ► Artikel lesen | |
| NEUROPACE | 16,960 | +0,89 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen | |
| BILLIONTOONE | 87,59 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,150 | -4,34 % | Privia Health stock rating initiated at Outperform by RBC Capital | ||
| SIEMENS HEALTHINEERS | 46,620 | +0,19 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| PACS GROUP | 41,365 | 0,00 % | RBC Capital reiterates Outperform rating on PACS Group stock | ||
| RXSIGHT | 9,570 | 0,00 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen |
INTEGRAL DIAGNOSTICS LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTEGRAL DIAGNOSTICS LIMITED finden Sie auf Wallstreet Online.